Arabic Arabic English English French French German German
dark

ViCentra Closes Series C Funding to Expand Its Insulin Pump in Europe

The proceeds from the $75 million funding will be used for the European launch of the company’s updated Kaleido insulin patch pump system. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

NRx Pharmaceuticals Files Counterclaim Against its Former Collaboration Partner, Relief Therapeutics

Next Post

Take These 6 Things Into Consideration In Choosing A Rehab Center

Related Posts
Total
0
Share